Postoperative Cognitive Dysfunction Completed Phase 4 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0036861 (Postoperative Cognitive Dysfunction)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00561678Perioperative Cognitive Function - Dexmedetomidine and Cognitive ReserveTreatment